# KETOROLAC TROMETHAMINE
> **ANDA216407** · Abbreviated New Drug Application (Generic) · Sponsor: ATNAHS PHARMA US · Approved 2022-10-21
## Drug
- **FDA Application Number:** ANDA216407
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** KETOROLAC TROMETHAMINE
- **Generic name:** KETOROLAC TROMETHAMINE
- **Active ingredients:** KETOROLAC TROMETHAMINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ATNAHS PHARMA US
- **Manufacturer:** ATNAHS PHARMA US LIMITED
- **First approval:** 2022-10-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216407)
---
*AI Analytics · CC0 1.0*